A fine balance between the level of injury amplification that can be tolerated and the benefits from long-term tumour suppression has likely been achieved through evolution, including a role for ROCK1 cleavage to limit the extent of sterile inflammation. The gene discussed is ROCK1; the disease is neoplasm.